Evaluation of the role of valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone.

Gavin Lucas, S. G. Mehta, Lynne Hocking, Tracy Lorraine Stewart, T. Cundy, G. C. Nicholson, J. P. Walsh, W. D. Fraser, G. D. Watts, S. H. Ralston, V. E. Kimonis

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Paget's disease of bone (PDB) is a common metabolic bone disease of late onset with a strong genetic component. Rarely, PDB can occur as part of a syndrome in which the disease is accompanied by inclusion body myopathy and frontotemporal dementia (inclusion body myopathy, Paget's disease and frontotemporal dementia, IBMPFD). Recently, IBMPFD has been shown to be caused by mutations in Valosin-containing Protein (VCP), which is required for the proteasomal degradation of phosphorylated I kappa B-alpha, a necessary step in the activation of the transcription factor NF-kappa B. Here, we evaluated the role of VCP in the pathogenesis of typical PDB. We conducted mutation screening of VCP in 44 kindreds with familial Paget's disease recruited mainly through clinic referrals in the UK, Australia and New Zealand. We also performed an association study of VCP haplotypes in patients with PDB who did not have a family history of the disease (sporadic PDB). No mutations were found in VCP in three PDB families where there was evidence of allele sharing between affected subjects in the VCP critical region on chromosome 9p13. We failed to detect disease-associated mutations in any of the three exons previously reported to contain IBMPFD mutations in a further 41 PDB families. We found no evidence of allelic association between common VCP haplotypes in a case-control study of 179 sporadic PDB patients and 172 age- and sex-matched controls. Genetic variation in VCP does not appear to be a common cause of familial or sporadic PDB in the absence of myopathy and dementia. (c) 2005 Elsevier Inc. All rights reserved.

Original languageEnglish
Pages (from-to)280-285
Number of pages5
JournalBone
Volume38
Issue number2
DOIs
Publication statusPublished - Feb 2006

Keywords

  • Paget's disease
  • ubiquitin
  • VCP genetic
  • NF-kappa B
  • inclusion-body myopathy
  • frontotemporal dementia
  • mutations
  • SQSTM1
  • gene
  • aggregation
  • proteasome
  • LOCI
  • P62

Cite this

Lucas, G., Mehta, S. G., Hocking, L., Stewart, T. L., Cundy, T., Nicholson, G. C., ... Kimonis, V. E. (2006). Evaluation of the role of valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone. Bone, 38(2), 280-285. https://doi.org/10.1016/j.bone.2005.07.014

Evaluation of the role of valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone. / Lucas, Gavin; Mehta, S. G.; Hocking, Lynne; Stewart, Tracy Lorraine; Cundy, T.; Nicholson, G. C.; Walsh, J. P.; Fraser, W. D.; Watts, G. D.; Ralston, S. H.; Kimonis, V. E.

In: Bone, Vol. 38, No. 2, 02.2006, p. 280-285.

Research output: Contribution to journalArticle

Lucas, G, Mehta, SG, Hocking, L, Stewart, TL, Cundy, T, Nicholson, GC, Walsh, JP, Fraser, WD, Watts, GD, Ralston, SH & Kimonis, VE 2006, 'Evaluation of the role of valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone.', Bone, vol. 38, no. 2, pp. 280-285. https://doi.org/10.1016/j.bone.2005.07.014
Lucas, Gavin ; Mehta, S. G. ; Hocking, Lynne ; Stewart, Tracy Lorraine ; Cundy, T. ; Nicholson, G. C. ; Walsh, J. P. ; Fraser, W. D. ; Watts, G. D. ; Ralston, S. H. ; Kimonis, V. E. / Evaluation of the role of valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone. In: Bone. 2006 ; Vol. 38, No. 2. pp. 280-285.
@article{dfea9deeed98486293c55aeb5bfaa8cd,
title = "Evaluation of the role of valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone.",
abstract = "Paget's disease of bone (PDB) is a common metabolic bone disease of late onset with a strong genetic component. Rarely, PDB can occur as part of a syndrome in which the disease is accompanied by inclusion body myopathy and frontotemporal dementia (inclusion body myopathy, Paget's disease and frontotemporal dementia, IBMPFD). Recently, IBMPFD has been shown to be caused by mutations in Valosin-containing Protein (VCP), which is required for the proteasomal degradation of phosphorylated I kappa B-alpha, a necessary step in the activation of the transcription factor NF-kappa B. Here, we evaluated the role of VCP in the pathogenesis of typical PDB. We conducted mutation screening of VCP in 44 kindreds with familial Paget's disease recruited mainly through clinic referrals in the UK, Australia and New Zealand. We also performed an association study of VCP haplotypes in patients with PDB who did not have a family history of the disease (sporadic PDB). No mutations were found in VCP in three PDB families where there was evidence of allele sharing between affected subjects in the VCP critical region on chromosome 9p13. We failed to detect disease-associated mutations in any of the three exons previously reported to contain IBMPFD mutations in a further 41 PDB families. We found no evidence of allelic association between common VCP haplotypes in a case-control study of 179 sporadic PDB patients and 172 age- and sex-matched controls. Genetic variation in VCP does not appear to be a common cause of familial or sporadic PDB in the absence of myopathy and dementia. (c) 2005 Elsevier Inc. All rights reserved.",
keywords = "Paget's disease, ubiquitin, VCP genetic, NF-kappa B, inclusion-body myopathy, frontotemporal dementia, mutations, SQSTM1, gene, aggregation, proteasome, LOCI, P62",
author = "Gavin Lucas and Mehta, {S. G.} and Lynne Hocking and Stewart, {Tracy Lorraine} and T. Cundy and Nicholson, {G. C.} and Walsh, {J. P.} and Fraser, {W. D.} and Watts, {G. D.} and Ralston, {S. H.} and Kimonis, {V. E.}",
year = "2006",
month = "2",
doi = "10.1016/j.bone.2005.07.014",
language = "English",
volume = "38",
pages = "280--285",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Evaluation of the role of valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone.

AU - Lucas, Gavin

AU - Mehta, S. G.

AU - Hocking, Lynne

AU - Stewart, Tracy Lorraine

AU - Cundy, T.

AU - Nicholson, G. C.

AU - Walsh, J. P.

AU - Fraser, W. D.

AU - Watts, G. D.

AU - Ralston, S. H.

AU - Kimonis, V. E.

PY - 2006/2

Y1 - 2006/2

N2 - Paget's disease of bone (PDB) is a common metabolic bone disease of late onset with a strong genetic component. Rarely, PDB can occur as part of a syndrome in which the disease is accompanied by inclusion body myopathy and frontotemporal dementia (inclusion body myopathy, Paget's disease and frontotemporal dementia, IBMPFD). Recently, IBMPFD has been shown to be caused by mutations in Valosin-containing Protein (VCP), which is required for the proteasomal degradation of phosphorylated I kappa B-alpha, a necessary step in the activation of the transcription factor NF-kappa B. Here, we evaluated the role of VCP in the pathogenesis of typical PDB. We conducted mutation screening of VCP in 44 kindreds with familial Paget's disease recruited mainly through clinic referrals in the UK, Australia and New Zealand. We also performed an association study of VCP haplotypes in patients with PDB who did not have a family history of the disease (sporadic PDB). No mutations were found in VCP in three PDB families where there was evidence of allele sharing between affected subjects in the VCP critical region on chromosome 9p13. We failed to detect disease-associated mutations in any of the three exons previously reported to contain IBMPFD mutations in a further 41 PDB families. We found no evidence of allelic association between common VCP haplotypes in a case-control study of 179 sporadic PDB patients and 172 age- and sex-matched controls. Genetic variation in VCP does not appear to be a common cause of familial or sporadic PDB in the absence of myopathy and dementia. (c) 2005 Elsevier Inc. All rights reserved.

AB - Paget's disease of bone (PDB) is a common metabolic bone disease of late onset with a strong genetic component. Rarely, PDB can occur as part of a syndrome in which the disease is accompanied by inclusion body myopathy and frontotemporal dementia (inclusion body myopathy, Paget's disease and frontotemporal dementia, IBMPFD). Recently, IBMPFD has been shown to be caused by mutations in Valosin-containing Protein (VCP), which is required for the proteasomal degradation of phosphorylated I kappa B-alpha, a necessary step in the activation of the transcription factor NF-kappa B. Here, we evaluated the role of VCP in the pathogenesis of typical PDB. We conducted mutation screening of VCP in 44 kindreds with familial Paget's disease recruited mainly through clinic referrals in the UK, Australia and New Zealand. We also performed an association study of VCP haplotypes in patients with PDB who did not have a family history of the disease (sporadic PDB). No mutations were found in VCP in three PDB families where there was evidence of allele sharing between affected subjects in the VCP critical region on chromosome 9p13. We failed to detect disease-associated mutations in any of the three exons previously reported to contain IBMPFD mutations in a further 41 PDB families. We found no evidence of allelic association between common VCP haplotypes in a case-control study of 179 sporadic PDB patients and 172 age- and sex-matched controls. Genetic variation in VCP does not appear to be a common cause of familial or sporadic PDB in the absence of myopathy and dementia. (c) 2005 Elsevier Inc. All rights reserved.

KW - Paget's disease

KW - ubiquitin

KW - VCP genetic

KW - NF-kappa B

KW - inclusion-body myopathy

KW - frontotemporal dementia

KW - mutations

KW - SQSTM1

KW - gene

KW - aggregation

KW - proteasome

KW - LOCI

KW - P62

U2 - 10.1016/j.bone.2005.07.014

DO - 10.1016/j.bone.2005.07.014

M3 - Article

VL - 38

SP - 280

EP - 285

JO - Bone

JF - Bone

SN - 8756-3282

IS - 2

ER -